Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
St. Luke's-Roosevelt Hospital Center
ClinicalTrials.gov Identifier:
NCT01401374
First received: July 21, 2011
Last updated: April 7, 2017
Last verified: April 2017
  Purpose
The study is an on-line survey posted on survey monkey that addresses some demographic and environmental issues that could potentially relate to vitiligo vulgaris onset or disease exacerbation.

Condition
Vitiligo Vulgaris

Study Type: Observational
Study Design: Observational Model: Other
Time Perspective: Other
Official Title: Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo

Resource links provided by NLM:


Further study details as provided by St. Luke's-Roosevelt Hospital Center:

Primary Outcome Measures:
  • Correlation of Disease State in Vitiligo with Clinical and Psychological Measures [ Time Frame: Self-reported retrospective single survey ]

Enrollment: 3258
Study Start Date: March 2011
Study Completion Date: March 2016
Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts
Vitiligo Patients
patients with vitiligo vulgaris
Controls
Individuals without vitiligo vulgaris

Detailed Description:
The survey is designed to look at some issues that are pertinent to individuals with vitiligo, including access to care, severity of disease, under-reported disease activity, causative and exacerbating factors and co-morbid illnesses.
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Individuals self-reporting vitiligo vulgaris and controls who do not have vitiligo vulgaris
Criteria

Inclusion Criteria:

  • Ability to complete survey

Exclusion Criteria:

  • Inability to complete survey
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01401374

Locations
United States, New York
St. Luke's-Roosevelt Hospital Center
New york, New York, United States, 10025
Sponsors and Collaborators
St. Luke's-Roosevelt Hospital Center
Investigators
Principal Investigator: Nanette Silverberg, MD St. Luke's-Roosevelt Hospital Center
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: St. Luke's-Roosevelt Hospital Center
ClinicalTrials.gov Identifier: NCT01401374     History of Changes
Other Study ID Numbers: 10-148/10-149x
Study First Received: July 21, 2011
Last Updated: April 7, 2017

Keywords provided by St. Luke's-Roosevelt Hospital Center:
Vitiligo Vulgaris
Autoimmunity
Thyroid Disease

Additional relevant MeSH terms:
Vitiligo
Hypopigmentation
Pigmentation Disorders
Skin Diseases

ClinicalTrials.gov processed this record on April 24, 2017